Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / *W EXP 12/17/202
-
Total 13F shares
-
4,670,066
-
Share change
-
-2,186,091
-
Total reported value
-
$654,653
-
Price per share
-
$0.14
-
Number of holders
-
23
-
Value change
-
-$223,218
-
Number of buys
-
1
-
Number of sells
-
2
Institutional Holders of Revolution Medicines, Inc. - *W EXP 12/17/202 (RVMDW) as of Q3 2024
As of 30 Sep 2024,
Revolution Medicines, Inc. - *W EXP 12/17/202 (RVMDW) was held by
23 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,670,066 shares.
The largest 10 holders included
D. E. Shaw & Co., Inc., PRICE T ROWE ASSOCIATES INC /MD/, ADAGE CAPITAL PARTNERS GP, L.L.C., SOROS CAPITAL MANAGEMENT LLC, Walleye Capital LLC, PERCEPTIVE ADVISORS LLC, Bleichroeder LP, COWEN AND COMPANY, LLC, Sculptor Capital LP, and Davidson Kempner Capital Management LP.
This page lists
21
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.